* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Wyeth Research

Exelixis Announces March 17 Webcast of Presentation at the Cowen and Company Annual Health Care...

yahoo.com
Mar 12, 2008 49 related
        

Exelixis, Inc. announced today that George A. Scangos, PhD, president and chief executive officer of Exelixis, will present at the Cowen and Company Annual Health Care Conference at 4:00 p.m. ... Wednesday March 12, 4:05 pm ET SOUTH SAN FRANCISCO, Calif., March 12...

add comment

MNTX Miss in Postoperative Ileus Drops Progenics' Stock

drugpolicycentral.com
Mar 13, 2008 4 related
        

(US) "There were no safety concerns that came out" of the POI Phase III study. (Wed Mar 12 17:48:48 2008 PDT)[$drug_related(100%), $drugwar_propaganda(60%), $propaganda_theme2(60%), $illegal_drugs(100%), $drugs(100%), $opioid(100%), $narcotic(100%), $various_drugs(100%)]

add comment

Wyeth, Progenics bowel drug fails in study

reuters.com
Mar 12, 2008 40 related
        

NEW YORK (Reuters) - Wyeth and Progenics Pharmaceuticals Inc said on Wednesday an intravenous form of their experimental bowel drug methylnaltrexone failed in a late-stage trial to improve gastrointestinal function following surgery. ... Preliminary results from the...

add comment

Progenics Pharmaceuticals, Inc. And Wyeth Provides Update On Phase 3 Clinical Trial Of...

pharmiweb.co.uk
Mar 12, 2008 3 related
        

Previous Page Page 1 Next Page Progenics Pharmaceuticals, Inc. And Wyeth Provides Update On Phase 3 Clinical Trial Of Intravenous Methylnaltrexone For Postoperative Ileus 5:35am EDT Progenics Pharmaceuticals, Inc. and Wyeth's Wyeth Pharmaceuticals, a division of Wyeth...

add comment

New Potential Treatment for Muscular Dystrophy Appears to Be Safe

physorg.com
Mar 11, 2008 7 related
        

Myostatin, a protein that blocks muscle growth, has shown promising results as a potential therapeutic target for treating muscular dystrophy in animal studies, where its inhibition led to increased muscle mass and strength. A new study, the first to evaluate a myostatin inhibitor in patients,...

add comment

Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference (PR Newswire)

yahoo.com
Mar 11, 2008 2 related
        

Pharmacopeia , an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the Cowen and Company 28th Annual Health Care Conference.

add comment

Breaking Stock Alert for Tuesday: MIHS! March 11, 2008 (Marketwire)

yahoo.com
Mar 11, 2008 21 related
        

Tuesday March 11, 9:35 am ET NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Stock Market Alerts' performance stock list includes: Medical Institutional Services Holdings, Inc (Other OTC: ), Tenet Healthcare Corp. (NYSE:THC -...

add comment

SCOLR Pharma, Inc. Reports Year End 2007 Financial Results (Business Wire)

yahoo.com
Mar 11, 2008
        

BELLEVUE, Wash.----SCOLR Pharma, Inc. today reported financial results for the fiscal year ended December 31, 2007. ... Tuesday March 11, 8:00 am ET BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD - The increase in royalty income from SCOLR’s alliance with...

add comment

SCOLR Pharma, Inc. Reports Year End 2007 Financial Results

pharmiweb.co.uk
Mar 11, 2008 1 related
        

Stockhouse Canada ... BELLEVUE, Wash., Mar 11, 2008 (BUSINESS WIRE) -- The increase in royalty income from SCOLR's alliance with Perrigo was offset by a decrease in research and development revenue due to the termination of its agreement with Wyeth Consumer Healthcare in...

add comment

CORRECTING and REPLACING Synygy Sales Operations Webcast Features Wyeth and U.S. Cellular Leaders

pharmiweb.co.uk
Mar 11, 2008 1 related
        

Yahoo! Canada ... Tuesday March 11, 10:37 am ET Online Panel on ''Ensuring Alignment of Strategy and Sales Compensation Plans: Assessing the Impact of Strategic Misalignment'' takes place March 5th CHESTER, Pa.--(BUSINESS WIRE)--Second graph, second sentence of release...

add comment